Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches: The Driving Engine Behind Polygenic Risk Score Services Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR) of 16.9%. This historic growth is attributed to factors such as the increasing incidence of chronic ailments, surging demand for tailor-made medicine, heightened awareness about genetic predispositions, wider access to consumer-directed genetic testing, and an increased acceptance of genomic research within the healthcare sector.

How Will the Polygenic Risk Score Services Market Size Evolve and Grow by 2029?
The market for polygenic risk score services is expected to experience rapid expansion in the coming years, with a projected worth of $2.68 billion by 2029 and an annual compound growth rate (CAGR) of 16.5%. This predicted growth within the forecast period can be linked to factors such as the increased use of artificial intelligence in genomics, the heightened demand for preventative healthcare solutions, an upsurge in investment towards genomic research and development, the broader integration of electronic health records with genetic information, and the growing accessibility of polygenic risk score-based testing services. Key trends during this forecast period are expected to include technological advancements in polygenic risk score algorithms, novel advancements in multi-omics data integration, progress in ancestry-informed polygenic risk scoring, research and progression in gene-environment interactions, and advancements within pharmacogenomics applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/polygenic-risk-score-services-global-market-report

What Drivers Are Propelling the Growth of Polygenic Risk Score Services Market Forward?
The push for personalized medicine, tailored to an individual's genetic, environmental, and lifestyle factors, is anticipated to fuel the expansion of the polygenic risk score services market. The rise of personalized medicine is a result of advancements in genomics, which offers in-depth insight into individual genetic variations and allows the application of more precise, targeted treatments that enhance patient outcomes and diminish the reliance on trial-and-error approaches. Polygenic risk score (PRS) services contribute to personalized medicine by examining multiple genetic variants to estimate an individual's potential to develop specific diseases. This allows healthcare professionals to develop individualized prevention strategies, early interventions, and treatment plans based on each patient's genetic profile. For example, the Personalized Medicine Coalition, a non-profit organization based in the United States, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, an increase from six in 2022. The newly approved treatments in 2023 also included seven cancer drugs and three for other diseases and conditions. Thus, the push for personalized medicine is facilitating the expansion of the polygenic risk score services market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28302&type=smp

Which Emerging Trends Are Transforming the Polygenic Risk Score Services Market in 2025?
Leading corporations in the polygenic risk score services market are concentrating on the creation of innovative solutions such as pharmacogenomics, with the objective of enhancing customized treatment strategies and bolstering patient outcomes. Pharmacogenomics is a field that examines how a person's genetic map determines their drug responses, thereby administering more accurate and personalized care. For example, in July 2025, Bupa, a health insurance firm based in the UK, unveiled a fresh collection of DNA-based tests designed to provide personalized health and wellness findings. This suite provides customized information on medication reactions and risk of diseases, paving way for timely detection and individualized treatment for illnesses like cancer, diabetes, and heart disease. These tests aid in avoiding adverse effects, enhancing long-term health results, and encouraging people to adopt proactive measures for their own well-being and that of their families. The goal is to transition healthcare from reactive treatment to preventive, precision health management.

What Are the Key Segments in the Polygenic Risk Score Services Market?
The polygenic risk score services market covered in this report is segmented as

1) By Service Type: Genotyping, Sequencing, Data Analysis, Reporting, Other Service Types
2) By Application: Disease Risk Assessment, Personalized Medicine, Research, Other Applications
3) By End-User: Hospitals And Clinics, Research Institutes, Direct-to-Consumer, Other End-Users

Subsegments:
1) By Genotyping: Array-Based Genotyping, Targeted Genotyping, High-Throughput Genotyping
2) By Sequencing: Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Targeted Sequencing
3) By Data Analysis: Polygenic Risk Prediction Algorithms, Bioinformatics And Statistical Analysis, Data Integration With Electronic Health Records (Ehr)
4) By Reporting: Clinical Reports For Healthcare Providers, Direct-To-Consumer (Dtc) Reports, Risk Stratification Reports (Disease-Specific)
5) By Other Service Types: Genetic Counseling Services, Data Storage And Cloud-Based Platforms, Prs Software And Toolkits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28302&type=smp

Who Are the Key Players Shaping the Polygenic Risk Score Services Market's Competitive Landscape?
Major companies operating in the polygenic risk score services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Illumina Inc., Endeavor Health Inc., Myriad Genetics Inc., The Broad Institute of MIT and Harvard, BGI Group, Invitae Corporation, 23andMe Holding Co., Color Health Inc., Genomics Ltd., Cogentech S.R.L., Gene by Gene Ltd., Our Future Health Ltd., Mapmygenome India Limited, Australian Genome Research Facility (AGRF) Ltd., Golden Helix Inc., Allelica Inc., Antegenes OÜ, GeninCode Plc.

What Geographic Markets Are Powering Growth in the Polygenic Risk Score Services Market?
North America was the largest region in the polygenic risk score services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polygenic risk score (PRS) services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28302

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.